Atea Pharmaceuticals, Inc.
AVIR
$4.49
$0.143.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -13.58% | 24.49% | |||
| Gross Profit | 13.58% | -24.49% | |||
| SG&A Expenses | -3.40% | -1.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.25% | 20.37% | |||
| Operating Income | 12.25% | -20.37% | |||
| Income Before Tax | 12.09% | -23.37% | |||
| Income Tax Expenses | 100.74% | -3,553.06% | |||
| Earnings from Continuing Operations | -1.28% | -6.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.28% | -6.70% | |||
| EBIT | 12.25% | -20.37% | |||
| EBITDA | 12.28% | -20.42% | |||
| EPS Basic | 0.09% | -7.97% | |||
| Normalized Basic EPS | 12.91% | -24.64% | |||
| EPS Diluted | 0.09% | -7.97% | |||
| Normalized Diluted EPS | 12.91% | -24.64% | |||
| Average Basic Shares Outstanding | 1.37% | -1.17% | |||
| Average Diluted Shares Outstanding | 1.37% | -1.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||